Month: April 2022

Company announcement 04/2022 Green Hydrogen Systems announces technical design complications in its HyProvide® A-Series platform Kolding, Denmark, 12 April 2022 – Green Hydrogen Systems announces technical design complications in its HyProvide® A-Series platform. The complications will impact the guidance for 2022 due to further delay in delivery of the order backlog. Recent testing and reviews conducted of the HyProvide® A-Series platform performance, have identified certain technical issues. These issues will require some redesign, as well as test and validation of certain product components and functions. As a consequence hereof, the delivery schedules will be adjusted and will impact the financial performance for 2022. Green Hydrogen Systems’ current guidance has been announced in company announcement no 1/2022 of 2 March 2022, where...

Total income for the first quarter of 2022 was EUR 3.6 million (first quarter 2021: EUR 3.8 million) Cash position further improved in the first quarter of 2022 Order book value increased with 16% compared to March 31, 2021Deventer, April 12, 2021 – RoodMicrotec N.V., a leading independent company for semiconductors supply and quality services, today releases its trading update for the first quarter of 2022. The total income for the quarter was EUR 3.6 million, which is 5% lower than the total income in the first quarter of 2021. In the first quarter of 2021, the total income included work in progress of EUR 0.5 million for SCM project preparations. With this adjustment, the total income for the first quarter of 2022 rose by 9% compared to the first quarter of 2021. “The cash position at the end of the first quarter of 2022 has further...

SAMPO PLC                 STOCK EXCHANGE RELEASE         12/04/2022 at 08:30 am Sampo plc’s share buybacks 11/04/2022 On 11/04/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  20,018 46.79 AQEU  29,828 46.80 CEUX  9,390 46.83 TQEX  90,764 46.81 XHELTOTAL 150,000 46.81  *rounded to two decimals                 On 30 March 2022, Sampo announced a share buyback programme of up to a maximum of EUR 250 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 31 March 2022, is...

  CGG Expands High-Performance Computing Capacity with New UK HPC Hub Paris, France – April 12, 2022 To support continued differentiation in its core business and accelerate the development of its new activities, CGG is significantly expanding its high-performance computing (HPC) capacity and associated service offerings. The company recently signed a lease to build a new European HPC hub in Southeast England that will become operational in H1 2023 and increase its cloud HPC capacity by up to 100 petaflops. Peter Whiting, EVP, Geoscience, CGG, said: “The expansion of our HPC capability at this new UK facility supports both the continued advance of our industry-leading subsurface imaging technology and services, as well as the growth of our specialized HPC offerings to new and existing clients in the energy, environmental and other industry...

NACON UNVEILS HELL IS US,THE NEW GAME FROM ROGUE FACTOR Lesquin, 12 April 2022 – NACON is pleased to announced Hell is Us, a new and major project from development studio Rogue Factor. The creative director on the project is Jonathan Jacques-Belletête, renown for his work on Deus Ex: Human Revolution, Deus Ex: Mankind Divided and more recently Marvel’s Guardians of the Galaxy before joining the team. Having been in development for several years, Hell is Us is the studio’s most ambitious project to date. Hell is Us is a third-person action-adventure game set in a semi-open world where the main character sets out to learn more about his past in a country ravaged by civil war. The almost total self-sufficiency of the country hides a dark secret: the recent appearance of supernatural creatures resembling ancient headstones and monuments...

Enclosed please find the Annual Report 2021 for Belships ASA (PDF and ESEF). The report is also available on our website www.belships.com. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsBelships ASA – Annual Report 20215967007LIEEXZXJCKO49-2021-12-31-en

The Annual General Meeting will be held at the Company’s premises at Lilleakerveien 6D, Oslo on Friday 6 May 2022 at 3.00 p.m. (CET). Notice of Annual General Meeting and attendance form/proxy form are enclosed and will also be made available on www.belships.com. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsBelships ASA – Notice of Annual general meetingBelships ASA – Innkalling til generalforsamling

BASEL, Switzerland and NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced today an update on the Supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis. In accordance with the ongoing review of the application, on April 6, 2022, the U.S. Food and Drug Administration (FDA) provided notice to the companies that the agency identified deficiencies that preclude discussion of labeling and/or post-marketing requirements and commitments at this time. The FDA did not provide additional detail. The FDA noted that the letter does not reflect a final decision on the pending sNDA and that the application is still under review. Myovant and Pfizer...